CVS Health (CVS) Stock Price Target Raised on Margin Recovery
Published on 5/11/2026
AI Summary
Mizuho has increased the stock price target for CVS Health (CVS) due to anticipated margin recovery. This revision signifies confidence in the company's ability to improve profitability, which could have a positive effect on its share price. The adjustment reflects ongoing market assessments regarding CVS's performance and operational efficiency. Analysts' price targets are significant indicators of expected market movements and investor sentiment.
Related News
Earnings
Oruka (ORKA) Insider Sale of $687K Amid 700% Stock Surge
Jun 27
Earnings
OneSpaWorld (OSW) Director Sells 10,500 Shares Amid Strong Q1 Revenue
Jun 27
M&A
Airbnb (ABNB) Faces Lawsuit in Chicago; Price Target Raised to $134
Jun 27
Earnings
Pfizer (PFE) Offers Attractive Dividend Yield for Investors
Jun 27